Evidence map›Paper›PMID 39092328›Full record

ArticleCureus2024

Effect of Topical Vancomycin on Surgical Site Infections in Ankle Fractures: A Randomized, Double-Blind, Controlled Trial.

Carlos A Acosta-Olivo, Alejandro Hernández-Alejo, Anna K Rangel-Alanís, Jorge A Elizondo-Rodríguez, Héctor M Zertuche-Garza, Yadira A Tamez-Mata, Víctor M Peña-Martínez, Mario Simental-Mendía

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carlos A Acosta-OlivoOrthopedic Trauma Service, School of Medicine, Dr. José Eleuterio González" University Hospital, Universidad Autónoma de Nuevo León, Monterrey, MEX.
Alejandro Hernández-AlejoOrthopedic Trauma Service, School of Medicine, Dr. José Eleuterio González" University Hospital, Universidad Autónoma de Nuevo León, Monterrey, MEX.
Anna K Rangel-AlanísOrthopedic Trauma Service, School of Medicine, Dr. José Eleuterio González" University Hospital, Universidad Autónoma de Nuevo León, Monterrey, MEX.
Jorge A Elizondo-RodríguezOrthopedic Trauma Service, School of Medicine, Dr. José Eleuterio González" University Hospital, Universidad Autónoma de Nuevo León, Monterrey, MEX.
Héctor M Zertuche-GarzaOrthopedic Trauma Service, School of Medicine, Dr. José Eleuterio González" University Hospital, Universidad Autónoma de Nuevo León, Monterrey, MEX.
Yadira A Tamez-MataOrthopedic Trauma Service, School of Medicine, Dr. José Eleuterio González" University Hospital, Universidad Autónoma de Nuevo León, Monterrey, MEX.
Víctor M Peña-MartínezOrthopedic Trauma Service, School of Medicine, Dr. José Eleuterio González" University Hospital, Universidad Autónoma de Nuevo León, Monterrey, MEX.
Mario Simental-MendíaOrthopedic Trauma Service, School of Medicine, Dr. José Eleuterio González" University Hospital, Universidad Autónoma de Nuevo León, Monterrey, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Applying topical vancomycin has shown a decrease in the likelihood of surgical site infections (SSIs) in surgeries linked to a heightened risk of severe and resistant infections. Nevertheless, the effectiveness of this prophylactic approach has not been assessed in open ankle surgeries with internal fixation. Objective This study aimed to assess whether topical vancomycin diminishes the risk of SSI in patients with ankle fractures undergoing open reduction with internal fixation. Methods A randomized, controlled, double-blind clinical trial was carried out. Patients were divided into two groups in a 1:1 ratio. The control group received the standard prophylactic treatment with IV cephalothin 1 g, while the intervention group was administered topical vancomycin (1 g) in addition to the standard prophylactic treatment. The main outcomes were the SSI rates at 14 days, 28 days, and three months post-surgery, based on relevant clinical signs and laboratory tests. Results One hundred thirty-two patients were randomized (51.2% female), with 66 subjects included in each intervention arm. A total of 97.7% of them completed the study. Both groups were homogeneous in baseline characteristics. There were two SSIs in both the vancomycin group (3.3%) and the control group (3.5%), with no statistical differences (p = 0.945). The microorganisms isolated as causal agents were

Indexed as

ankle fracturesinternal fixationopen fracture reductionrandomized clinical trialvancomycin powder

Identifiers

PMID39092328
PMCPMC11293790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.